Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Axogen Inc (NQ: AXGN ) 12.92 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Axogen Inc < Previous 1 2 3 4 Next > CytoSorbents Appoints Peter J. Mariani Chief Financial Officer August 13, 2024 CytoSorbents CFO Kathleen P. Bloch Retires From CytoSorbents Via GlobeNewswire AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday August 08, 2024 Via Benzinga Axogen Earnings Preview March 04, 2024 Via Benzinga Axogen, Inc. Announces New Leadership Appointments August 08, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. Reports Second Quarter 2024 Financial Results August 08, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 July 23, 2024 From Axogen, Inc. Via GlobeNewswire Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) July 01, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™ June 24, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia May 28, 2024 Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector Growth From Axogen, Inc. Via GlobeNewswire Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft® May 16, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference May 14, 2024 From Axogen, Inc. Via GlobeNewswire AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024 May 02, 2024 AXGN stock results show that Axogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Axogen, Inc Reports First Quarter 2024 Financial Results May 02, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ April 29, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 April 16, 2024 From Axogen, Inc. Via GlobeNewswire AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023 March 05, 2024 AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results March 05, 2024 From Axogen, Inc. Via GlobeNewswire Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Via Benzinga Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 February 13, 2024 From Axogen, Inc. Via GlobeNewswire Earnings Scheduled For March 5, 2024 March 05, 2024 Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. Via Benzinga Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) February 02, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap January 18, 2024 From Axogen, Inc. Via GlobeNewswire Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales January 05, 2024 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Shares of Applied Therapeutics, Inc. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 05, 2024 Via Benzinga Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday January 05, 2024 U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply during Friday’s session following upbeat... Via Benzinga Topics Stocks Exposures US Equities Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 January 04, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 January 04, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Announces Promotions on Research and Development Team January 04, 2024 Company Also Announces Departure of Angelo Scopelianos, Ph.D. From Axogen, Inc. Via GlobeNewswire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.